In light of Medicare finally forcing big pharma to do what it has to do and negotiate drug prices, I want to talk about a tool to let everyone know how much your physician is paid by big pharma – so you can see how those payments may impact the drugs prescribed to you and your family.
The Open Payments database is a treasure trove of information designed to increase transparency within the healthcare industry. It’s a tool that empowers patients, researchers, policymakers, and the public to better understand the financial relationships between healthcare providers and the pharmaceutical and medical device companies whose products they prescribe or use.
The database is divided into three primary categories:
General Payments: This category encompasses a wide range of payments made by pharmaceutical and medical device companies to healthcare providers and teaching hospitals. These payments include consulting fees, travel expenses, meals, gifts, and speaking fees. It’s a comprehensive view of the financial transactions that occur within the industry.
Research Payments: Research is a critical component of advancing medical knowledge and treatments. In this category, you’ll find information on payments related to research activities conducted by healthcare providers and teaching hospitals on behalf of these companies. This includes research funding, grants, and other research-related payments.
Ownership Investments: Transparency extends to financial interests as well. This category reveals any ownership interests that healthcare providers or their immediate family members may hold in pharmaceutical or medical device companies. Such investments could influence a provider’s decisions and practices.
The beauty of the Open Payments database lies in the power of data. While it may seem impossible to know how much the pharmaceutical industry pays physicians for prescribing their drugs, this database provides a glimpse into these financial relationships. Let’s delve deeper into how this data can be used.
The pharmaceutical industry plays a crucial role in healthcare, but it’s essential that their interactions with healthcare providers remain transparent and ethical. The Open Payments database serves as a tool for accountability, allowing watchdog organizations, journalists, and policymakers to scrutinize the financial transactions between drug companies and healthcare providers. This scrutiny can help identify potential areas of concern and ensure that the industry operates ethically.
Transparency is a powerful motivator for ethical behavior. When healthcare providers know that their financial relationships with pharmaceutical companies are open to public scrutiny, they are more likely to make decisions that prioritize patient well-being over financial gain. This transparency promotes ethical practices within the healthcare industry.
The Open Payments Search Tool is a remarkable resource that brings transparency to an often opaque corner of the healthcare industry. It allows individuals and organizations to investigate the financial ties between pharmaceutical and medical device companies and healthcare providers. By shedding light on these relationships, Open Payments empowers patients, holds the industry accountable, promotes ethical practices, and enhances research integrity. In an era where transparency is paramount, this tool is a beacon of light guiding us toward a more open and ethical healthcare system.
Given the vast quantity of information published by the federal government, Medicare Administrative Contractors (MACs), consultants, and others, it can be easy to lose track
Recent updates to the Health Insurance Portability and Accountability Act (HIPAA) represent the most significant shift in healthcare privacy and security requirements in over a
Please log in to your account to comment on this article.
Uncover essential coding insights with nationally recognized coding authority Kay Piper, RHIA, CDIP, CCS. Through ICD10monitor’s interactive, on‑demand webcast series, Kay walks you through the AHA’s 2026 ICD‑10‑CM/PCS Quarterly Coding Clinics, translating each update into practical, easy‑to‑apply guidance designed to sharpen precision, ensure compliance, and strengthen day‑to‑day decision‑making. Available shortly after each official release.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s fourth quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s third quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s second quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Federal auditors are intensifying their focus on inpatient psychiatric facilities, using advanced data analytics to spotlight outliers and pursue high‑dollar repayments. In this high‑impact webcast, Michael Calahan, PA, MBA, Compliance Officer and V.P., Hospital & Physician Compliance, breaks down what regulators are really targeting in IPF-PPS admissions, documentation, treatment and discharge planning. Attendees will learn practical steps to tighten processes, avoid common audit triggers and protect reimbursement and reduce the risk of multimillion-dollar repayment demands.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
BLOOM INTO SAVINGS! Get 25% OFF during our spring sale through March 27. Use code SPRING26 at checkout to claim this offer.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
